Influence of smoking and body weight on adipokines in middle aged women

European Journal of Medical Research

Volumn 14, Issue SUPPL.4, 2009, Pages 21-26

  Bergmann, S ^a   Siekmeier, R ^b  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Federal Institute for Drugs and Medical Devices (BfArM)   (Germany)

Author keywords

adipokines; inflammation; smoking; women

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 6; LEPTIN; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD; BODY MASS; BODY WEIGHT; FEMALE; HUMAN; MIDDLE AGED; SMOKING;

ADIPOKINES; ADIPONECTIN; ADULT; AGED; BODY MASS INDEX; BODY WEIGHT; C-REACTIVE PROTEIN; FEMALE; HUMANS; INTERLEUKIN-6; LEPTIN; MIDDLE AGED; SERUM AMYLOID A PROTEIN; SMOKING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955502349     PISSN: 09492321     EISSN: 2047783X     Source Type: Journal    
DOI: 10.1186/2047-783X-14-S4-21     Document Type: Article

References (41)

1. Primary prevention of coronary heart disease in women through diet and lifestyle. Stampfer MJ, Hu FB, Manson JE, Rimm EB, Willett WC, N Engl J Med 2000 343 16 22 10.1056/NEJM200007063430103 10882764 (Pubitemid 30447987)
2. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW, Arterioscler Thromb Vasc Biol 1999 19 972 8 10.1161/01.ATV.19.4.972 10195925 (Pubitemid 29177345)
3. Leukocyte count, smoking, and myocardial infarction. Zalokar JB, Richard JL, Claude JR, N Engl J Med 1981 304 465 8 10.1056/NEJM198102193040806 7453772 (Pubitemid 11179004)
4. Even moderate cigarette smoking influences the pattern of circulating monocytes and the concentration of sICAM-1. Bergmann S, Siekmeier R, Mix C, Jaross W, Respir Physiol 1998 114 269 75 10.1016/S0034-5687(98)00098-X 9926990 (Pubitemid 29050874)
5. C-reactive protein in patients with chronic stable angina: differences in baseline serum concentration between women and men. Garcia-Moll X, Zouridakis E, Cole D, Kaski JC, Eur Heart J 2000 21 1598 606 10.1053/euhj.2000.2128 10988012
6. Effect of smoking habit on circulating adipokines in diabetic and non-diabetic subjects. Al Mutairi SS, Mojiminiyi OA, Shihab-Eldeen AA, Al SA, Abdella N, Ann Nutr Metab 2008 52 329 34 10.1159/000151487 18714151
7. Smoking cessation increases serum adiponectin levels in an apparently healthy Greek population. Efstathiou SP, Skeva II, Dimas C, et al. Atherosclerosis 2009
8. Leptin, CRP und Leukozyten bei moderaten Raucherinnen. Bergmann S, Richter F, Assig K, Siekmeier R, Atemw-Lungenkrkh 2007 33 318 23 (Pubitemid 47441122)
9. Comparison of risk factors for coronary heart disease in Dresden and Munster. Results of the DRECAN (Dresden Cardiovascular Risk and Nutrition) study and the PROCAM (Prospective Cardiovascular Munster) Study. Jaross W, Assmann G, Bergmann S, Schulte H, Eur J Epidemiol 1994 10 307 15 10.1007/BF01719355 7859842 (Pubitemid 24315560)
10. Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Canoy D, Wareham N, Luben R, et al. Obes Res 2005 13 1466 75 10.1038/oby.2005.177 16129730
11. Adiponectin and metabolic syndrome. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I, Arterioscler Thromb Vasc Biol 2004 24 29 33 10.1161/01.ATV. 0000099786.99623.EF 14551151 (Pubitemid 38082408)
12. Review article: adipocytokines and insulin resistance. Vettor R, Milan G, Rossato M, Federspil G, Aliment Pharmacol Ther 2005 22 Suppl 2 3 10 16225463 (Pubitemid 41564373)
13. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Arita Y, Kihara S, Ouchi N, et al. Biochem Biophys Res Commun 1999 257 79 83 10.1006/bbrc.1999.0255 10092513 (Pubitemid 29299050)
14. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Ziccardi P, Nappo F, Giugliano G, et al. Circulation 2002 105 804 9 10.1161/hc0702.104279 11854119 (Pubitemid 34174919)
15. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. Yang WS, Lee WJ, Funahashi T, et al. J Clin Endocrinol Metab 2001 86 3815 9 10.1210/jc.86.8.3815 11502817 (Pubitemid 32755982)
16. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Gustafson B, Hammarstedt A, Andersson CX, Smith U, Arterioscler Thromb Vasc Biol 2007 27 2276 83 10.1161/ATVBAHA.107.147835 17823366 (Pubitemid 350203940)
17. Adiponectin as an anti-inflammatory factor. Ouchi N, Walsh K, Clin Chim Acta 2007 380 24 30 10.1016/j.cca.2007.01.026 17343838 (Pubitemid 46498041)
18. Adipocytokine profile of type 2 diabetics in metabolic syndrome as defined by various criteria. Al-Daghri NM, Al-Attas OS, Al-Rubeaan K, Sallam R, Diabetes Metab Res Rev 2008 24 52 8 10.1002/dmrr.763 17657721 (Pubitemid 351176000)
19. Dual suppression of adipogenesis by cigarette smoke through activation of the aryl hydrocarbon receptor and induction of endoplasmic reticulum stress. Shimada T, Hiramatsu N, Hayakawa K, et al. Am J Physiol Endocrinol Metab 2009 296 721 E730 10.1152/ajpendo.90829.2008 19141685
20. Serum adiponectin is associated with smoking status in healthy Korean men. Sull JW, Kim HJ, Yun JE, et al. Endocr J 2009 56 73 8 10.1507/endocrj.K08E- 231 18840926
21. Serum leptin concentrations are not related to dietary patterns but are related to sex, age, body mass index, serum triacylglycerol, serum insulin, and plasma glucose in the US population. Ganji V, Kafai MR, McCarthy E, Nutr Metab (Lond) 2009 6 3 10.1186/1743-7075-6-3
22. Smoking cessation is associated with increased plasma adiponectin levels in men. Otsuka F, Kojima S, Maruyoshi H, et al. J Cardiol 2009 53 219 25 10.1016/j.jjcc.2008.11.004 19304126
23. Gender differences in serum leptin levels in humans. Hickey MS, Israel RG, Gardiner SN, et al. Biochem Mol Med 1996 59 1 6 10.1006/bmme.1996.0056 8902186 (Pubitemid 26346750)
24. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. Considine RV, Sinha MK, Heiman ML, et al. N Engl J Med 1996 334 292 5 10.1056/NEJM199602013340503 8532024 (Pubitemid 26033933)
25. Effects of smoking status and smoking cessation on leptin levels. Perkins KA, Fonte C, Nicotine Tob Res 2002 4 459 66 10.1080/1462220021000018434 12521405 (Pubitemid 35469980)
26. Enhanced pulmonary leptin expression in patients with severe COPD and asymptomatic smokers. Vernooy JH, Drummen NE, van Suylen RJ, et al. Thorax 2009 64 26 32 18835960
27. Adiponectin decreases C-reactive protein synthesis and secretion from endothelial cells: evidence for an adipose tissue-vascular loop. Devaraj S, Torok N, Dasu MR, Samols D, Jialal I, Arterioscler Thromb Vasc Biol 2008 28 1368 74 10.1161/ATVBAHA.108.163303 18451326
28. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. Fernandez-Real JM, Vayreda M, Richart C, et al. J Clin Endocrinol Metab 2001 86 1154 9 10.1210/jc.86.3.1154 11238501 (Pubitemid 32322997)
29. The effect of weight loss on C-reactive protein: a systematic review. Selvin E, Paynter NP, Erlinger TP, Arch Intern Med 2007 167 31 9 10.1001/archinte.167.1.31 17210875 (Pubitemid 46072404)
30. Contribution of adipocytokines to low-grade inflammatory state as expressed by circulating C-reactive protein in Japanese men: comparison of leptin and adiponectin. Sugiura K, Tamakoshi K, Yatsuya H, et al. Int J Cardiol 2008 130 159 64 10.1016/j.ijcard.2008.01.006 18495270
31. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Ouchi N, Kihara S, Funahashi T, et al. Circulation 2003 107 671 4 10.1161/01.CIR.0000055188.83694.B3 12578865 (Pubitemid 36222590)
32. Association between adiponectin and mediators of inflammation in obese women. Engeli S, Feldpausch M, Gorzelniak K, et al. Diabetes 2003 52 942 7 10.2337/diabetes.52.4.942 12663465 (Pubitemid 36384264)
33. Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation. Matsubara M, Namioka K, Katayose S, Eur J Endocrinol 2003 148 657 62 10.1530/eje.0.1480657 12773138 (Pubitemid 36758296)
34. Hormone replacement therapy and increased plasma concentration of C-reactive protein. Ridker PM, Hennekens CH, Rifai N, Buring JE, Manson JE, Circulation 1999 100 713 6 10.1161/01.CIR.100.7.713 10449692 (Pubitemid 29383640)
35. Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women. Barinas-Mitchell E, Cushman M, Meilahn EN, Tracy RP, Kuller LH, Am J Epidemiol 2001 153 1094 101 10.1093/aje/153.11.1094 11390329 (Pubitemid 32493259)
36. Circulating adiponectin and plasma fatty acid profile. Fernandez-Real JM, Vendrell J, Ricart W, Clin Chem 2005 51 603 9 10.1373/clinchem.2004.041350 15637134 (Pubitemid 40300237)
37. Adiponectin inhibits endothelial synthesis of interleukin-8. Kobashi C, Urakaze M, Kishida M, et al. Circ Res 2005 97 1245 52 10.1161/01.RES.0000194328. 57164.36 16269654
38. Obesity and leptin. Hauner H, Dtsch Med Wochenschr 1998 123 1315 6 9824967 (Pubitemid 28515776)
39. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM, J Clin Invest 1995 95 2409 15 10.1172/JCI117936 7738205
40. The role of TNF-alpha in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. Popa C, Netea MG, van Riel PL, van der Meer JW, Stalenhoef AF, J Lipid Res 2007 48 751 62 10.1194/jlr.R600021-JLR200 17202130 (Pubitemid 46557880)
41. Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity. Zahorska-Markiewicz B, Janowska J, Olszanecka-Glinianowicz M, Zurakowski A, Int J Obes Relat Metab Disord 2000 24 1392 5 10.1038/sj.ijo. 0801398 11126333